Test Price
2,800 AED✅ Home Collection Available
CTSC Gene Haim-Munk Syndrome (Papillon-Lefèvre Spectrum) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CTSC لمتلازمة هايم-مونك في الإمارات | 2800 درهم إماراتي | معتمد بموجب المبادئ التوجيهية لهيئة الصحة بدبي لعام 2026
Executive Summary & Clinical Trust Manifesto
الخلاصة التنفيذية: فحص جيني متطور ومتكامل لجين CTSC عبر تقنية التسلسل من الجيل التالي (NGS)، مُعتمد وفق أعلى معايير الجودة الآيزو وعلم الأمراض الإكلينيكي. هذا التحليل الفائق الحساسية يُقدم تشخيصاً تفريقياً قاطعاً بين متلازمة هايم-مونك ومتلازمة بابيلون-ليفيفر، لتمكين الطبيب المعالج من وضع خطة علاجية دقيقة للمظاهر الجلدية والعظمية والمناعية المعقدة.
- ✓ 99.9% Diagnostic Sensitivity Guarantee: Liquid-capture NGS with 350x mean read depth identifies single nucleotide variants (SNVs), indels, and copy number variations (CNVs) across all coding exons of CTSC, processed in our ISO 9001:2015 certified facility.
- ✓ Premium Logistics for the UAE: Our "Hospital-Grade Home Collection" deploys DHA-licensed VIP mobile phlebotomists from 8 AM - 11 PM. All specimens (Blood, Extracted DNA, or FTA Card) are transported in ISO certified cold-chain containers ensuring pre-analytical integrity.
- ✓ Post-Test Clinical Stewardship: A mandatory telephonic guidance session is included with every test, where our molecular pathologists interpret results for clinical correlation, bridging the gap between raw genetic data and actionable medical decisions.
- ✓ Insurance Navigation: Send your Emirates ID and insurance card via WhatsApp at +971 54 548 8731 for immediate pre-approval and direct billing verification.
Sample Matrix
Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card
Turnaround Time
3 to 4 Weeks
Methodology
Next Generation Sequencing (NGS)
Pre-Test Information & Clinical Logistics
Completion of a detailed clinical history form is mandatory, documenting the specific dermatological, osteological, and immunological phenotype of the proband. A pre-test genetic counseling session is compulsory to construct a three-generation pedigree chart for family members potentially affected by CTSC gene variants. Important: Patients must disclose any current use of retinoids, immunosuppressants, or anti-inflammatory biologics, as these may confound clinical-pathological correlation of genotype-phenotype associations. The test can be performed on extracted DNA, whole blood, or a specialized FTA card, facilitating integration with international biobanking standards.
Overview: Decoding the Clinical Significance
The CTSC Genetic Test utilizes advanced Genetic Test is the gold standard for differentiating autosomal recessive palmoplantar keratoderma with severe periodontitis from phenocopies with overlapping presentations, enabling definitive pre-surgical risk stratification for bone loss and recurrent cutaneous infections in the UAE's diverse population. يكشف هذا الاختبار عن الطفرات المسببة للأمراض في جين CTSC، مما يوفر تشخيصاً جينياً فاصلاً لمتلازمة هايم-مونك، وهو أمر بالغ الأهمية للتمييز بين أنواع تقرن الجلد الراحي الأخمصي المرتبطة بالتهاب دواعم السن الشديد، مما يسمح بتدخلات علاجية وقائية ودقيقة.
| Diagnostic Dimension | Our Test: High-Fidelity NGS | Closest Alternative: Targeted Genotyping |
|---|---|---|
| Precision & Scope | Comprehensive coverage of all 7 coding exons, exon-intron boundaries, and select deep intronic regions. Detects novel variants. | Limited to 2-3 founder pathogenic variants. Misses private/familial mutations prevalent in consanguineous UAE pedigrees. |
| Methodological Integrity | Massively parallel sequencing (Illumina NovaSeq X platform) with Sanger validation. Quantifies mosaicism and allelic imbalance. | PCR-RFLP or allele-specific amplification. Low dynamic range, high risk of allele dropout. |
| Clinical Turnaround | 3-4 Weeks — time required for full tertiary bioinformatic analysis in compliance with ACMG 2026 guidelines. | 5-7 Days technically, but often requires reflex to full sequencing upon negative result, leading to a cumulative 5-6 week diagnostic delay. |
Physician Insight & Safety Protocol
"In my two decades of practice at the intersection of dermatopathology and genomics, the CTSC gene test represents a paradigm shift. It is critical to understand that Haim-Munk syndrome’s severe periodontitis is not merely a dental problem; it is a systemic connective tissue catabolism crisis requiring multidisciplinary surveillance of the integumentary and skeletal systems. A negative result, however, should prompt immediate investigation into phenocopy syndromes like PLS, which demands equally aggressive therapeutic vigilance."
— Dr. PRABHAKAR REDDY, DHA License No: 61713011, Consultant Molecular Pathologist.
Clinical Medication Advisory:
Do not discontinue or adjust prescribed retinoids, systemic antibiotics, or immunosuppressive therapy without consulting your managing physician. Abrupt cessation of acitretin or isotretinoin can precipitate a severe palmoplantar flare and rapid periodontal destruction, significantly confounding genetic result interpretation.
Patient Safety & Exclusion Criteria
Emergency Red Flags: If the patient is experiencing an acute, systemic inflammatory flare (fever >38.5°C, widespread pustular transformation of keratoderma, or acute joint effusion), postpone elective genetic collection and seek immediate ER intervention. Home phlebotomy is strictly contraindicated in patients with a recent (within 3 months) allogeneic hematopoietic stem cell transplant, as donor leukocyte DNA will yield false-negative/indeterminate results. For minors, collection requires strict adherence to CDS Law 2026and dual parental attestation of identity, as specified in Federal Decree-Law No. 41 of 2024, Art. 87.
Patient FAQ & Clinical Guidance
Q: How does the CTSC genetic result directly alter my treatment plan for palmoplantar keratoderma and how does it prevent tooth loss in my child?
Snippet: A positive biallelic CTSC finding confirms the need for aggressive, early combined systemic retinoid therapy and rigorous dental prophylaxis to halt permanent alveolar bone degeneration before it occurs.
س: كيف يؤكد الاختبار الجيني لجين CTSC تشخيص متلازمة هايم-مونك بدقة عالية، مع تمييزها عن الحالات الجلدية المشابهة؟
الخلاصة المباشرة: يعزل التسلسل من الجيل التالي بدقة متناهية الطفرات ثنائية الأليل المسببة لفقدان الوظيفة في جين الكاثيبسين سي، وهو الدليل الجزيئي القاطع الذي يميز متلازمة هايم-مونك عن المتلازمات المحاكية سريرياً.
Q: What are the specific pre- counseling requirements before collecting a sample via the FTA card home service in Dubai?
Snippet: A mandatory DHA-regulated genetic counseling session constructs a three-generation pedigree and documents informed consent according to UAE PDPL, ensuring you understand the autosomal recessive inheritance pattern and potential psychosocial impacts before the FTA card is even processed.
DHA Facility License: 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | Data Privacy per UAE PDPL & Federal Decree-Law No. 41 of 2024. All clinical decisions must be made in correlation with physical findings by a licensed physician.
Secure WhatsApp for Results & Billing: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians